Public Company News

Appian Congratulates 2021 International Partner Award Winners

LONDON, Sept. 14, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced its 2021 International Partner Award Winners at Appian Europe, a low-code automation virtual conference. This annual award, now in its fourth year, recognizes top strategic partners that have successfully deployed sol...

2021-09-14 21:09 5528

EdgeVerve's AssistEdge 19.0 to Empower Human-Digital workforce to Build High-Performance Enterprise

Enterprises to experience connected automation that will connect people, processes & data to unlock enterprise-wide benefits BENGALURU, India, Sept. 14, 2021 /PRNewswire/ -- EdgeVerve Systems , a wholly-owned subsidiary of Infosys  (NSE: INFY...

2021-09-14 20:31 6164

83% of IT and business leaders say adapting to change requires better apps and infrastructure, according to Economist Intelligence Unit report supported by Appian

Supporting remote workers (72%), integrating information and workflows across the organization (69%), and changing systems and processes quickly (69%) are the top 3 areas for improvement LONDON, Sept. 14, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the availability of "IT's changi...

2021-09-14 16:01 1423

Appian Announces the Latest Version of the Appian Low-Code Automation Platform

MCLEAN, Va., Sept. 14, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the latest version of theAppian Low-Code Automation Platform. The new release makes it faster and more efficient to build enterprise applications through major enhancements in low-code data, complete automation func...

2021-09-14 16:00 3455

BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs

VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...

2021-09-14 15:00 6436

iQIYI Sports Teams Up with Barça and Launches the "iBarça Membership"

BEIJING, Sept. 14, 2021 /PRNewswire/ -- iQIYI Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service inChina, is pleased to announce that onSeptember 14, the Company expands its existing strategic collaboration with Barça to develop a new premium m...

2021-09-14 15:00 5416

Veoneer provides update regarding discussions with Qualcomm

STOCKHOLM, Sept. 14, 2021 /PRNewswire/ -- The automotive technology company Veoneer, Inc. (NYSE: VNE) and (SSE: VNE SDB) today confirmed that it has received an updated non-binding proposal from Qualcomm Incorporated providing for the acquisition of all of the outstanding shares of Veoneer at a p...

2021-09-14 11:29 9267

Risen Energy wins EcoVadis bronze rating for its commitment to green and sustainable development

NINGBO, China, Sept. 14, 2021 /PRNewswire/ -- Risen Energy recently received a bronze rating fromFrance-based EcoVadis for its superior performance. The company has long been committed to sustainable development as the guiding principle for its social responsibility efforts while also being activ...

2021-09-14 10:00 6381

CStone presents updated data from registrational clinical study of sugemalimab in patients with stage IV NSCLC in an oral presentation at IASLC 2021 WCLC

* Data with the longer follow-up showed that sugemalimab plus chemotherapy continued to demonstrate improvement in progression-free survival (PFS), after the primary efficacy endpoint was met at an interim PFS analysis last year * The updated data showed that the risk of disease progression or...

2021-09-14 08:30 5172

Global Investors Invest in Etana

JAKARTA, Indonesia, Sept. 14, 2021 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana)has secured a new round of investment led by Legend Capital along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). This round of funds will b...

2021-09-14 08:00 7567

Clarivate Announces Winner of Eugene Garfield Award 2021

Elena Pallari receives $25,000 for proposal for innovation in clinical research assessment LONDON, Sept. 13, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today namedElena Pallari, Department of...

2021-09-13 23:33 5730

Supermicro Expands Total Solution Portfolio by Offering Nutanix NX Platforms for Hybrid Multi-cloud Solutions

Supermicro Takes Longstanding Strategic Relationship to the Next Level by Offering the Nutanix NX Solutions Based on Supermicro Ultra and BigTwin Systems through the Nutanix Elevate Partner Program SAN JOSE, Calif., Sept. 13, 2021 /PRNewswire/ -- Super Micro Computer, Inc. (SMCI), a global leade...

2021-09-13 21:05 7074

Ping An Named Insurance Company of the Year, ESG, China by The Asset

HONG KONG and SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) is pleased to announce that the Group has been named Insurance Company of the Year, ESG,China at The Asset Triple A Insurance Awards 2...

2021-09-13 20:03 11245

IR Collaborate adds over 200,000 new managed users

Key takeaways: * More than 200,000 new users managed by IR Collaborate  since 1 July 2021. * Managed user growth is driven by significant product investment, including expanded support for Microsoft Teams, Zoom and Webex. * IR Collaborate now ensure...

2021-09-13 19:15 2861

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 6910

Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest" or the "Company") announced today two separate definitive agreements ("Agreements") withProvidence Therapeutics Holdings Inc.

2021-09-13 17:00 5603

Joy Spreader's Interim Results Press Conference: Data Accumulation, Data Analytics and Algorithm Modeling Form the Core of the Firm's Strengths

BEIJING, Sept. 13, 2021 /PRNewswire/ -- According to the interim financial report for 2021 recently released by Joy Spreader Group Inc. (HKG:6988, "the Group", "Joy Spreader"), a leading marketing technology company listed inHong Kong, the Group's spend on research and development (R&D) rose to H...

2021-09-13 15:59 3541

Forrester: 24% Of Indian Brands Delivered Poorer Customer Experiences In 2021

NEW DELHI, Sept. 13, 2021 /PRNewswire/ -- According to Forrester's  (Nasdaq: FORR) 2021 India Customer Experience Index (CX Index™) , only four out of 29 brands managed to significantl...

2021-09-13 15:46 9702

Markel opens Paris branch to support small and medium-sized enterprises in the French market

LONDON, Sept. 13, 2021 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that it has opened a new branch office inParis to support small and medium-sized enterprises (SMEs) in the French market. The move is part of a longstanding strategy to further expand and scale the company's gl...

2021-09-13 15:00 8820

Crocs Announces Second Collaboration with G Flip

SYDNEY, Sept. 13, 2021 /PRNewswire/ -- Crocs, INC. (NADSAQ: CROX), a global leader in innovative casual footwear for women, men and children, today announced a second collaboration with Australian musician G Flip, dropping exclusively atPlatypus Shoes  and on h...

2021-09-13 10:00 5745
1 ... 854855856857858859860 ... 901